The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
Open accessAbstract
A central hurdle in developing small interfering RNAs (siRNAs) as therapeutics is the inefficiency of their delivery across the plasma and endosomal membranes to the cytosol, where they interact with the RNA interference machinery. With the aim of improving endosomal release, a poorly understood and inefficient process, we studied the uptake and cytosolic release of siRNAs, formulated in lipoplexes or lipid nanoparticles, by live-cell imaging and correlated it with knockdown of a target GFP reporter. siRNA release occurred invariably from maturing endosomes within ~5-15 min of endocytosis. Cytosolic galectins immediately recognized the damaged endosome and targeted it for autophagy. However, inhibiting autophagy did not enhance cytosolic siRNA release. Gene knockdown occurred within a few hours of release and required <2,000 copies of cytosolic siRNAs. The ability to detect cytosolic release of siRNAs and understand how it is regulated will facilitate the development of rational strategies for improving the cytosolic delivery of candidate drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“∼2000 cytoplasmic siRNAs are estimated to achieve maximal silencing, whereas ∼50 000 are required for an ASO [54, 55].”
From Elucidating brain transport pathways and cell type-dependent gene silencing of a durable lipid–siRNA conjugate administered into cerebrospinal fluid (2025) · cites this paper as [54]
In the citing paper
“Indeed, only a small amount of lipid nanoparticles may be able to escape from the endosome137–139.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [139]
In the citing paper
“Following cellular internalization, lipid nanoparticles are usually trapped in endosomal compartments137–139.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954
Huotari, J., & Helenius, A. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.286 · Cited by 2,448
Kimura, S., Noda, T., & Yoshimori, T. (2007) · Autophagy · doi:10.4161/auto.4451 · Cited by 2,278
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
Self-citationDelivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681
Lentivirus-delivered stable gene silencing by RNAi in primary cells.
Stewart, S. A., Dykxhoorn, D. M., Palliser, D., Mizuno, H., Yu, E. Y., An, D., Sabatini, D., Chen, I. S. Y., Hahn, W., Sharp, P., et al. (2003) · RNA: A publication of the RNA Society · doi:10.1261/rna.2192803 · Cited by 1,619
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Self-citationMaximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
Self-citationTargeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 690
Pattipeiluhu, R., Zeng, Y., Hendrix, M. M. R. M., Voets, I. K., Kros, A., & Sharp, T. H. (2024) · Nature Communications · doi:10.1038/s41467-024-45666-5 · Cited by 132
Tanaka, H., Takahashi, T., Konishi, M., Takata, N., Gomi, M., Shirane, D., Miyama, R., Hagiwara, S., Yamasaki, Y., Sakurai, Y., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910575 · Cited by 126
Mild Innate Immune Activation Overrides Efficient Nanoparticle‐Mediated RNA Delivery
Lokugamage, M. P., Gan, Z., Zurla, C., Levin, J., Islam, F. Z., Kalathoor, S., Sato, M., Sago, C. D., Santangelo, P. J., & Dahlman, J. E. (2020) · Advanced Materials · doi:10.1002/adma.201904905 · Cited by 126
Huang, X., Chuang, L. I. U., Kong, N., Xiao, Y., Yurdagul, A., Tabas, I. A., & Tao, W. (2022) · Nature Protocols · doi:10.1038/s41596-021-00665-4 · Cited by 126
How do oral insecticidal compounds cross the insect midgut epithelium?
Denecke, S., Swevers, L., Douris, V., & VONTAS, J. G. (2018) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2018.10.005 · Cited by 125
Challenges and opportunities for siRNA-based cancer treatment
Wang, T., Shigdar, S. L., Shamaileh, H. A., Gantier, M. P., Yin, W., Xiang, D., Wang, L., Zhou, S.-F., Hou, Y., Wang, P., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.045 · Cited by 123
Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t
Juliano, R. L. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0727 · Cited by 125
Nakamura, T., Sato, Y., Yamada, Y., Abd Elwakil, M. M., Kimura, S., Younis, M. A., & Harashima, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114417 · Cited by 121
Kilchrist, K. V., Dimobi, S. C., Jackson, M. A., Evans, B. C., Werfel, T. A., Dailing, E. A., Bedingfield, S. K., Kelly, I. B., & Duvall, C. L. (2019) · ACS Nano · doi:10.1021/acsnano.8b05482 · Cited by 124
Nucleic acid delivery with extracellular vesicles
Schulz‐Siegmund, M., & Aigner, A. M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.005 · Cited by 124
Endosomal Escape and Cytosolic Penetration of Macromolecules Mediated by Synthetic Delivery Agents
Brock, D. J., Kondow-McConaghy, H. M., Hager, E. C., & Pellois, J. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00799 · Cited by 122
Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
Trepotec, Z., Lichtenegger, E., Plank, C., Aneja, M. K., & Rudolph, C. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.012 · Cited by 115
Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol
Johansson, J. M., Rietz, H. D., Hedlund, H., Eriksson, H. C., Blenke, E. O., Pote, A. R., Harun, S., Nordenfelt, P., Lindfors, L., & Wittrup, A. (2025) · Nature Communications · doi:10.1038/s41467-025-60959-z · Cited by 131
Self-citationGuo, Y., Lee, H., Fang, Z., Velalopoulou, A. P., Kim, J., Thomas, M. B., Liu, J., Abramowitz, R. G., Kim, Y., Coskun, A. F., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf7390 · Cited by 114
Haghighi, E., Abolmaali, S. S., Dehshahri, A., Shaegh, S. A. M., Azarpira, N., & Tamaddon, A. M. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02972-w · Cited by 121
Gao, Y., Li, J., Wang, Q., Hu, H., Zhao, X., Chen, D., & Qiao, M. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b02016 · Cited by 110
Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs
Johannes, L., & Lucchino, M. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0716 · Cited by 110
How Do Biomolecules Cross the Cell Membrane?
Pei, D. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00560 · Cited by 106
Chen, Z., Tian, Y., Yang, J., Wu, F., Liu, S., Cao, W., Xu, W., Hu, T., Siegwart, D. J., & Xiong, H. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c09143 · Cited by 108
Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects
Kruspe, S., & Giangrande, P. H. (2017) · Biomedicines · doi:10.3390/biomedicines5030045 · Cited by 106
Liver Injury and Regeneration: Current Understanding, New Approaches, and Future Perspectives
Hora, S., & Wüestefeld, T. (2023) · Cells · doi:10.3390/cells12172129 · Cited by 109
Sato, Y., Note, Y., Maeki, M., Kaji, N., Baba, Y., Tokeshi, M., & Harashima, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.019 · Cited by 108
Dobrowolski, C. N., Paunovska, K., Echeverri, E. S., Loughrey, D., Sanchez, A. J. D. S., Ni, H., Hatit, M. Z. C., Lokugamage, M. P., Kuzminich, Y., Peck, H. E., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01146-9 · Cited by 113
Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma
Yin, H., Sun, L., Pu, Y., Yu, J., Feng, W., Dong, C., Zhou, B., Du, D., Zhang, Y., Chen, Y., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c01143 · Cited by 102
Lipid Nanoparticle Technologies for Nucleic Acid Delivery: A Nanoarchitectonics Perspective
Ferhan, A. R., Park, S.-H., Park, H., Tae, H., Jackman, J. A., & Cho, N. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202203669 · Cited by 103
Review of structural design guiding the development of lipid nanoparticles for nucleic acid delivery
Cárdenas, M., Campbell, R. A., Arteta, M. Y., Lawrence, M. J., & Sebastiani, F. (2023) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2023.101705 · Cited by 108
Recent advances in siRNA delivery for cancer therapy using smart nanocarriers
Zhang, P., An, K., Duan, X., Xu, H., Li, F., & Xu, F. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.042 · Cited by 102
All‐In‐One Dendrimer‐Based Lipid Nanoparticles Enable Precise HDR‐Mediated Gene Editing In Vivo
Farbiak, L., Cheng, Q., Wei, T., Álvarez‐Benedicto, E., Johnson, L. T., Lee, S. M., & Siegwart, D. J. (2021) · Advanced Materials · doi:10.1002/adma.202006619 · Cited by 103
Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides
Moss, K. H., Popova, P. G., Hadrup, S. R., Astakhova, K., & Taskova, M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01290 · Cited by 101
Nanoparticle entry into cells; the cell biology weak link
Griffiths, G. W., Grüenberg, J., Marsh, M., Wohlmann, J., Jones, A. T., & Parton, R. G. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114403 · Cited by 101
Advances in gene-based vaccine platforms to address the COVID-19 pandemic
Pushparajah, D., Jimenez, S., Wong, S. L., Alattas, H., Nafissi, N., & Slavcev, R. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.003 · Cited by 99
Wang, Z., Wang, L., Prabhakar, N., Xing, Y., Rosenholm, J. M., Zhang, J., & Cai, K. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.01.002 · Cited by 99
Binzel, D. W., Li, X., Burns, N., Khan, E., Lee, W.-J., Chen, L.-C., Ellipilli, S., Miles, W. O., Ho, Y. S., & Guo, P. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00009 · Cited by 97
Strategies and mechanisms for endosomal escape of therapeutic nucleic acids
Grau, M., & Wagner, E. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102506 · Cited by 96
Messenger RNA-Based Vaccines Against Infectious Diseases
Alameh, M.-G., Weissman, D., & Pardi, N. (2020) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2020_202 · Cited by 96
Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia
Hu, B., Li, B., Li, K., Liu, Y., Li, C., Zheng, L., Zhang, M., Yang, T., Guo, S., Dong, X., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm1418 · Cited by 95
Dong, Y., Chen, Y., Zhu, D., Shi, K., Ma, C., Zhang, W., Rocchi, P., Jiang, L., & Liu, X. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.003 · Cited by 94
Self-citationmiRNA Delivery by Nanosystems: State of the Art and Perspectives
Moraes, F. C., Pichon, C., Letourneur, D., & Chaubet, F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111901 · Cited by 93
Engineering nanoparticle toolkits for mRNA delivery
Sun, B., Wu, W., Narasipura, E. A., Ma, Y., Yu, C., Fenton, O. S., & Song, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115042 · Cited by 96
Nawaz, M., Heydarkhan‐Hagvall, S., Tangruksa, B., González‐King, H., Jing, Y., Maugeri, M., Kohl, F., Hultin, L., Reyahi, A., Camponeschi, A., et al. (2023) · Advanced Science · doi:10.1002/advs.202206187 · Cited by 93
Lou, B., Koker, S. D., Lau, C. Y. J., Hennink, W. E., & Mastrobattista, E. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00524 · Cited by 92
Caveolae-Mediated Endocytosis Drives Robust siRNA Delivery of Polymeric Nanoparticles to Macrophages
Song, Y., Wu, Y., Xu, L., Jiang, T., Tang, C., & Yin, C. (2021) · ACS Nano · doi:10.1021/acsnano.0c08596 · Cited by 90
Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation
Wang, J., Su, W., Zhang, T., Zhang, S., Lei, H., Ma, F., Shi, M., Shi, W., Xie, X., & Di, C. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05763-7 · Cited by 93
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Choi, Y., Seok, S. H., Yoon, H. Y., Ryu, J. H., & Kwon, I. C. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115306 · Cited by 92
Zhu, J., Qiao, M., Wang, Q., Ye, Y., Ba, S., Ma, J., Hu, H., Zhao, X., & Chen, D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.042 · Cited by 88
The siRNAsome: A Cation‐Free and Versatile Nanostructure for siRNA and Drug Co‐delivery
Zheng, M., Jiang, T., Yang, W., Zou, Y., Wu, H., Liu, X., Zhu, F., Qian, R., Ling, D., McDonald, K. L., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814289 · Cited by 88
Self-citationLiu, Z., Zhou, W. Y., Cheng, Q., & Kong, T. (2020) · Advanced Materials · doi:10.1002/adma.202002932 · Cited by 90
Branching Ionizable Lipids Can Enhance the Stability, Fusogenicity, and Functional Delivery of mRNA
Hashiba, K., Sato, Y., Taguchi, M., Sakamoto, S., Otsu, A., Maeda, Y., Shishido, T., Murakawa, M., Arimichi, O., & Harashima, H. (2022) · Small Science · doi:10.1002/smsc.202200071 · Cited by 91
Fluorinated Lipid Nanoparticles for Enhancing mRNA Delivery Efficiency
Zhang, H., Meng, C., Yi, X., Han, J., Wang, J., Liu, F., Ling, Q., Li, H., & Gu, Z. (2024) · ACS Nano · doi:10.1021/acsnano.3c04507 · Cited by 91
siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases
Kalita, T., Dezfouli, S. A., Pandey, L. M., & Uludağ, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112520 · Cited by 90
Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery
Mollé, L. M., Smyth, C. H., Yuen, D., & Johnston, A. P. R. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1809 · Cited by 95
Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems
Weiss, A. M., Hossainy, S., Rowan, S. J., Hubbell, J. A., & Esser-Kahn, A. P. (2022) · Macromolecules · doi:10.1021/acs.macromol.2c00854 · Cited by 89
Aliakbarinodehi, N., Gallud, A., Mapar, M., Wesén, E. V., Heydari, S., Jing, Y., Emilsson, G., Liu, K., Sabirsh, A., Zhdanov, V. P., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c04829 · Cited by 89
Alshehri, A. A., Grabowska, A. M., & Stolnik, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-22166-3 · Cited by 86
Cationic micelle: A promising nanocarrier for gene delivery with high transfection efficiency
Wang, H., Ding, S., Zhang, Z., Wang, L., & You, Y. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3101 · Cited by 85
Vickers, T. A., & Crooke, S. T. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv920 · Cited by 84
Liu, H., Wang, M., Hu, X., Shi, S., & Xu, P. (2020) · Small · doi:10.1002/smll.202003398 · Cited by 83
Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach
Freitag, F., & Wagner, E. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.03.005 · Cited by 83
The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA
Barbieri, B. D., Peeler, D. J., Samnuan, K., Day, S., Hu, K., Sallah, H., Tregoning, J. S., McKay, P. F., & Shattock, R. J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.016 · Cited by 85
Microfluidic self-assembly of folate-targeted monomolecular siRNA-lipid nanoparticles
Krzysztoń, R., Salem, B., Lee, D.-J., Schwake, G., Wagner, E., & Rädler, J. O. (2017) · Nanoscale · doi:10.1039/c7nr01593c · Cited by 82
Zhang, T., Huang, Y., Ma, X., Gong, N., Liu, X., Liu, L., Ye, X., Hu, B., Li, C., Tian, J., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02553 · Cited by 80
Self-citationSynthetic Approaches for Nucleic Acid Delivery: Choosing the Right Carriers
Ni, R., Feng, R., & Chau, Y. (2019) · Life · doi:10.3390/life9030059 · Cited by 84
Uehara, K., Harumoto, T., Makino, A., Koda, Y., Iwano, J., Suzuki, Y., Tanigawa, M., Iwai, H., Asano, K., Kurihara, K., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac308 · Cited by 80
Zhou, J., Wu, Y., Wang, C., Cheng, Q., Han, S., Wang, X., Zhang, J., Deng, L., Zhao, D., Du, L., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02915 · Cited by 78
Kirschman, J. L., Bhosle, S. M., Vanover, D. A., Blanchard, E. L., Loomis, K. H., Zurla, C., Murray, K. A., Lam, B. C., & Santangelo, P. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx290 · Cited by 77
de Vyver, T. V., Bogaert, B., Backer, L. D., Joris, F., Guagliardo, R., Hoeck, J. V., Merckx, P., Calenbergh, S. V., Ramishetti, S., Peer, D., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c00666 · Cited by 77
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
Paskeh, M. D. A., Saebfar, H., Mahabady, M. K., Orouei, S., Hushmandi, K., Entezari, M., Hashemi, M., Aref, A. R., Hamblin, M. R., Ang, H. L., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120463 · Cited by 77
Intracellular transport of nanocarriers across the intestinal epithelium
Fan, W., Xia, D., Zhu, Q., Hu, L., & Gan, Y. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.04.007 · Cited by 77
Comparing photoporation and nucleofection for delivery of small interfering RNA to cytotoxic T cells
Wayteck, L., Xiong, R., Braeckmans, K., Smedt, S. C. D., & Raemdonck, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.002 · Cited by 79
Miller, J. B., Zhang, S., Kós, P., Xiong, H., Zhou, K., Perelman, S. S., Zhu, H., & Siegwart, D. J. (2016) · Angewandte Chemie · doi:10.1002/ange.201610209 · Cited by 74
Lee, S. H., Song, J. G., & Han, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.036 · Cited by 72
Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival
Werfel, T. A., Wang, S., Jackson, M. A., Kavanaugh, T. E., Joly, M. M., Lee, L., Hicks, D. J., Sanchez, V. M., Ericsson, P. I. G., Kilchrist, K. V., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2388 · Cited by 73
Somiya, M. (2020) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00552-9 · Cited by 76
Leveraging Biological Buffers for Efficient Messenger RNA Delivery via Lipid Nanoparticles
Henderson, M. I., Eygeris, Y., Jozić, A., Herrera‐Barrera, M., & Sahay, G. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00587 · Cited by 71
Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery
Hatit, M. Z. C., Dobrowolski, C. N., Lokugamage, M. P., Loughrey, D., Ni, H., Zurla, C., Sanchez, A. J. D. S., Radmand, A., Huayamares, S. G., Zenhausern, R., et al. (2023) · Nature Chemistry · doi:10.1038/s41557-023-01138-9 · Cited by 71
TECPR1 is activated by damage‐induced sphingomyelin exposure to mediate noncanonical autophagy
Kaur, N., de la Ballina, L. R., Haukaas, H. S., Torgersen, M. L., Radulovic, M., Munson, M. J., Sabirsh, A., Stenmark, H., Simonsen, A., Carlsson, S. R., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022113105 · Cited by 72
Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
Liu, Z., Wang, S., Tapeinos, C., Torrieri, G., Känkänen, V., El‐Sayed, N., Python, A., Hirvonen, J. J., & Santos, H. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.018 · Cited by 73
The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
Ye, Z., Harmon, J., Ni, W., Li, Y., Wich, D., & Xu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.2c12584 · Cited by 72
Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles
Tesei, G., Hsiao, Y., Dabkowska, A. P., Grönberg, G., Arteta, M. Y., Ulkoski, D., Bray, D. J., Trulsson, M., Ulander, J., Lund, M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311700120 · Cited by 70
Breaking free: endocytosis and endosomal escape of extracellular vesicles
Ribovski, L., Joshi, B. S., Gao, J., & Zuhorn, I. S. (2023) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.26 · Cited by 75
Deprey, K. L., Batistatou, N., & Kritzer, J. A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa576 · Cited by 71
Using Large Datasets to Understand Nanotechnology
Paunovska, K., Loughrey, D., Sago, C. D., Langer, R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201902798 · Cited by 69
Karaki, S., Benizri, S., Mejías, R., Baylot, V., Branger, N., Nguyen, D. T., Vialet, B., Oumzil, K., Barthélémy, P., & Rocchi, P. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.042 · Cited by 66
RetractedSuzuki, Y., Hyodo, K., Suzuki, T., Tanaka, Y., Kikuchi, H., & Ishihara, H. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.016 · Cited by 64
Nanoparticle‐mediated siRNA delivery systems for cancer therapy
Gao, H. J., Cheng, R., & Santos, H. A. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200111 · Cited by 62
Therapeutic RNA Delivery for COVID and Other Diseases
Dobrowolski, C. N., Paunovska, K., Hatit, M. Z. C., Lokugamage, M. P., & Dahlman, J. E. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002022 · Cited by 62
Endosomal Escape of Lipid Nanoparticles: A Perspective on the Literature Data
Pei, D. (2025) · ACS Nano · doi:10.1021/acsnano.5c11721 · Cited by 64
Tang, X., Zhang, J., Sui, D., Yang, Q., Wang, T., Xu, Z., Li, X., Gao, X., Yan, X., Liu, X., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.008 · Cited by 61
Self-citationpH-Dependent Phase Behavior and Stability of Cationic Lipid–mRNA Nanoparticles
Larson, N. R., Hu, G., Wei, Y., Tuesca, A. D., Forrest, M. L., & Middaugh, C. R. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.11.004 · Cited by 61
Mehta, M. J., Kim, H. J., Lim, S. B., Naito, M., & Miyata, K. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202300366 · Cited by 61
Engineered multi-domain lipid nanoparticles for targeted delivery
Liu, Z., Chen, J., Xu, M., Ho, S., Wei, Y., Ho, H., & Yong, K. (2025) · Chemical Society Reviews · doi:10.1039/d4cs00891j · Cited by 63
Joris, F., Backer, L. D., de Vyver, T. V., Bastiancich, C., Smedt, S. C. D., & Raemdonck, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.019 · Cited by 60
Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
Gareri, C., Polimeni, A., Giordano, S. A., Tammè, L., Curcio, A., & Indolfi, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133884 · Cited by 62
Porciani, D., Cardwell, L. N., Tawiah, K. D., Alam, K. K., Lange, M. J., Daniëls, M. A., & Burke, D. H. (2018) · Nature Communications · doi:10.1038/s41467-018-04691-x · Cited by 58
Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies
Yu, L., Liu, S., Jia, S., & Xu, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115049 · Cited by 59
Suzuki, Y., & Ishihara, H. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.124 · Cited by 57
Sato, Y., Okabe, N., Note, Y., Hashiba, K., Maeki, M., Tokeshi, M., & Harashima, H. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.022 · Cited by 57
Lin, Y., Wilk, U., Pöhmerer, J., Hörterer, E., Höhn, M., Luo, X., Mai, H., Wagner, E., & Lächelt, U. (2022) · Small · doi:10.1002/smll.202205318 · Cited by 58
Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles
O’Brien, M. N., Foley, D. A., Pak, R. H., Lewis, J. A., McKinney, E., Egan, P. M., Yerabolu, R., Dane, E. L., Dirat, O., Gorka, L. S., et al. (2025) · Nature Nanotechnology · doi:10.1038/s41565-024-01833-9 · Cited by 57
Li, X., Li, J., Wei, J., Du, W., Su, C., Shen, X., Zhao, A., & Xu, M. (2025) · MedComm · doi:10.1002/mco2.70414 · Cited by 60
Metadata
- Authors
- Wittrup, A., Ai, A., Liu, X., Hamar, P., Trifonova, R., Charisse, K., Manoharan, M., Kirchhausen, T., & Lieberman, J.
- Affiliations
- Boston Children's Hospital (US)
- Alnylam Pharmaceuticals (United States) (US)
- Corresponding author
- Wittrup, Anders
- Lieberman, Judy
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2015-07-20
- Volume
- 33
- Issue
- 8
- Pages
- 870-876
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4663660
- OpenAlex
- W1844274376
- Cited by
- 693
- References
- 30
- Citations by year
- 2026: 101 · 2025: 104 · 2024: 82 · 2023: 60 · 2022: 59 · 2021: 63 · 2020: 53 · 2019: 40 · 2018: 54 · 2017: 37 · 2016: 31 · 2015: 8
- FWCI
- 18.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA139444, CA139444)
- National Institute of General Medical Sciences (GM075252, R01GM075252)
- National Institute of Allergy and Infectious Diseases (AI090671, AI057159, R01AI090671, U54AI057159)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- siRNA delivery, endosomal escape, lipoplexes, lipid nanoparticles, endocytosis, autophagy, galectins, gene knockdown, live-cell imaging, RNA interference, siRNA therapeutics
- MeSH terms
- HeLa Cells, Humans, Lipids, Luminescent Proteins, Endosomes, RNA Interference, RNA, Small Interfering, Nanoparticles, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review